E
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 11 Jun 2025)
What this means for you
Registered since 11 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88388296
- Registration number
- 5986237
- Mark type
- Design + words
- Filed
- 16 Apr 2019
- Published for opposition
- 13 Aug 2019
- Registered
- 11 Feb 2020
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care [ ; nutritional and dietary supplements; vitamins and mineral supplements; food supplements ]
Owner
- ENDO OPERATIONS LIMITED, BALLSBRIDGE, IE
- Endo Pharmaceuticals Inc., Malvern, PA, US
- Endo Pharmaceuticals Inc., Malvern, PA, US
- Endo Pharmaceuticals Inc., Malvern, PA, US
Prior registrations
Prosecution history
- 11 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 11 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 11 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Feb 2025 — TEAS SECTION 8 & 15 RECEIVED
- 11 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Jun 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 01 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Dec 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Jun 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 11 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 09 Jan 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jan 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Nov 2019 — USE AMENDMENT FILED
- 29 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL